Deletion and aberrant CpG island methylation of Caspase 8 gene in medulloblastoma
Related Experiment Video
Updated: Aug 23, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Pilar Gonzalez-Gomez1, M Josefa Bello, M Mar Inda
1Laboratorio de Oncogenética Molecular y Epigenética del Cáncer, Departamento de C. Experimental, Unidad de Investigación, Hospital Universitario La Paz, Paseo Castellana 261, 28046 Madrid, Spain.
Abstract:
Aberrant methylation of promoter CpG islands in human genes is an alternative genetic inactivation mechanism that contributes to the development of human tumors. Nevertheless, few studies have analyzed methylation in medulloblastomas. We determined the frequency of aberrant CpG island methylation for Caspase 8 (CASP8) in a group of 24 medulloblastomas arising in 8 adult and 16 pediatric patients. Complete methylation of CASP8 was found in 15 tumors (62%) and one case displayed hemimethylation. Three samples amplified neither of the two primer sets for methylated or unmethylated alleles, suggesting that genomic deletion occurred in the 5' flanking region of CASP8. Our findings suggest that methylation commonly contributes to CASP8 silencing in medulloblastomas and that homozygous deletion or severe sequence changes involving the promoter region may be another mechanism leading to CASP8 inactivation in this neoplasm.
Insights
Aberrant methylation of the Caspase 8 (CASP8) gene is common in medulloblastomas, potentially silencing this tumor suppressor. Genomic deletions may also contribute to CASP8 inactivation in these brain tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant DNA methylation of gene promoter CpG islands is a known mechanism for tumor development.
- Medulloblastomas, a common pediatric brain tumor, have been understudied regarding promoter methylation.
- Caspase 8 (CASP8) is a key mediator of apoptosis, and its silencing can promote tumor growth.
Purpose of the Study:
- To determine the frequency of aberrant CpG island methylation in the CASP8 gene in medulloblastomas.
- To investigate potential alternative mechanisms of CASP8 inactivation in these tumors.
Main Methods:
- Analysis of CASP8 promoter CpG island methylation in 24 medulloblastoma samples (16 pediatric, 8 adult).
- Use of methylation-specific PCR with primers for methylated and unmethylated alleles.
- Assessment for genomic alterations in the CASP8 5' flanking region.
Main Results:
- Complete CASP8 methylation was observed in 62% (15/24) of medulloblastomas.
- One tumor exhibited hemimethylation of CASP8.
- Genomic deletion or significant sequence changes in the CASP8 promoter region were suggested in three samples.
Conclusions:
- CpG island methylation is a frequent mechanism contributing to CASP8 silencing in medulloblastomas.
- Homozygous deletion or severe promoter sequence alterations represent another potential pathway for CASP8 inactivation in this neoplasm.
- These findings highlight the importance of CASP8 in medulloblastoma pathogenesis and suggest therapeutic targets.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Caspases
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

